NCT02114658
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +16 more
- Locations
-
- Kobe, Hyōgo, Japan
- Matsumoto, Nagano, Japan
- Bunkyo-ku, Tokyo, Japan
- Koto-ku, Tokyo, Japan
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,768 public trials
494 recruiting studies
Neuroendocrine Tumors trial results
NCT01252251
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +11 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT01253564
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- CHUV; Departement d'Oncologie Lausanne, Switzerland
- Universitätsspital Zürich; Dermatologische Klinik Zurich, Switzerland
Completed
Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
NCT00107718
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Santa Monica, California, United States
- GSK Investigational Site New Haven, Connecticut, United States
NCT01143402
- Conditions
- Eye Diseases, Eye Neoplasms, Iris Melanoma, +17 more
- Locations
-
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- Mount Sinai Medical Center Miami Beach, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
Completed
Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers
NCT01528774
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +42 more
- Locations
-
- Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States
NCT00949702
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- UCLA - School of Medicine; Division of Hematology/Oncology Los Angeles, California, United States
- University of Colorado Denver, Colorado, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Massachusetts General Hospital;Hematology/ Oncology Boston, Massachusetts, United States
NCT01928940
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- GSK Investigational Site Shizuoka, Japan
- GSK Investigational Site Tokyo, Japan
Completed
Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam
NCT02082665
- Conditions
- Cancer, Melanoma, Neoplasms, +10 more
- Locations
-
- GSK Investigational Site Lebanon, New Hampshire, United States
- GSK Investigational Site Barcelona, Spain
- GSK Investigational Site Madrid, Spain
- GSK Investigational Site Seville, Spain
NCT00434252
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
Not specified